Structure-guided optimization of SLC1A1/EAAT3-selective inhibitors targeting renal cancer metabolism.
Saved in:
| Title: | Structure-guided optimization of SLC1A1/EAAT3-selective inhibitors targeting renal cancer metabolism. |
|---|---|
| Authors: | Koochaki P; Department of Cancer Sciences, Cleveland Clinic Research, Cleveland, OH, USA., Qiu B; Department of Physiology & Biophysics, Weill Cornell Medicine, New York, NY, USA.; Howard Hughes Medical Institute, Weill Cornell Medicine, New York, NY, USA., Coker JA; Center for Therapeutics Discovery, Cleveland Clinic Research, Cleveland, OH, USA.; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Case Western Reserve University, Cleveland, OH, USA., Earsley A; Department of Physiology & Biophysics, Weill Cornell Medicine, New York, NY, USA., Wang NS; Center for Therapeutics Discovery, Cleveland Clinic Research, Cleveland, OH, USA., Romigh T; Center for Therapeutics Discovery, Cleveland Clinic Research, Cleveland, OH, USA., Goins CM; Center for Therapeutics Discovery, Cleveland Clinic Research, Cleveland, OH, USA.; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Case Western Reserve University, Cleveland, OH, USA., Salem C; Department of Cancer Sciences, Cleveland Clinic Research, Cleveland, OH, USA., Mi D; Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA., Days E; Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA., Bauer JA; Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA., Stauffer SR; Center for Therapeutics Discovery, Cleveland Clinic Research, Cleveland, OH, USA. stauffs2@ccf.org.; Department of Pharmacology, Case Western Reserve University, Cleveland, OH, USA. stauffs2@ccf.org., Boudker O; Department of Physiology & Biophysics, Weill Cornell Medicine, New York, NY, USA. olb2003@med.cornell.edu.; Howard Hughes Medical Institute, Weill Cornell Medicine, New York, NY, USA. olb2003@med.cornell.edu., Chakraborty AA; Department of Cancer Sciences, Cleveland Clinic Research, Cleveland, OH, USA. chakraa@ccf.org.; Department of Pharmacology, Case Western Reserve University, Cleveland, OH, USA. chakraa@ccf.org.; Case Comprehensive Cancer Center, Cleveland, OH, USA. chakraa@ccf.org. |
| Source: | The EMBO journal [EMBO J] 2026 Jun; Vol. 45 (11), pp. 3763-3787. Date of Electronic Publication: 2026 Apr 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2075 (Electronic) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42020573 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Structure-guided optimization of SLC1A1/EAAT3-selective inhibitors targeting renal cancer metabolism. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Koochaki+P%22">Koochaki P</searchLink>; Department of Cancer Sciences, Cleveland Clinic Research, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Qiu+B%22">Qiu B</searchLink>; Department of Physiology & Biophysics, Weill Cornell Medicine, New York, NY, USA.; Howard Hughes Medical Institute, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Coker+JA%22">Coker JA</searchLink>; Center for Therapeutics Discovery, Cleveland Clinic Research, Cleveland, OH, USA.; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Case Western Reserve University, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Earsley+A%22">Earsley A</searchLink>; Department of Physiology & Biophysics, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Wang+NS%22">Wang NS</searchLink>; Center for Therapeutics Discovery, Cleveland Clinic Research, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Romigh+T%22">Romigh T</searchLink>; Center for Therapeutics Discovery, Cleveland Clinic Research, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Goins+CM%22">Goins CM</searchLink>; Center for Therapeutics Discovery, Cleveland Clinic Research, Cleveland, OH, USA.; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Case Western Reserve University, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Salem+C%22">Salem C</searchLink>; Department of Cancer Sciences, Cleveland Clinic Research, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Mi+D%22">Mi D</searchLink>; Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Days+E%22">Days E</searchLink>; Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Bauer+JA%22">Bauer JA</searchLink>; Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Stauffer+SR%22">Stauffer SR</searchLink>; Center for Therapeutics Discovery, Cleveland Clinic Research, Cleveland, OH, USA. stauffs2@ccf.org.; Department of Pharmacology, Case Western Reserve University, Cleveland, OH, USA. stauffs2@ccf.org.<br /><searchLink fieldCode="AU" term="%22Boudker+O%22">Boudker O</searchLink>; Department of Physiology & Biophysics, Weill Cornell Medicine, New York, NY, USA. olb2003@med.cornell.edu.; Howard Hughes Medical Institute, Weill Cornell Medicine, New York, NY, USA. olb2003@med.cornell.edu.<br /><searchLink fieldCode="AU" term="%22Chakraborty+AA%22">Chakraborty AA</searchLink>; Department of Cancer Sciences, Cleveland Clinic Research, Cleveland, OH, USA. chakraa@ccf.org.; Department of Pharmacology, Case Western Reserve University, Cleveland, OH, USA. chakraa@ccf.org.; Case Comprehensive Cancer Center, Cleveland, OH, USA. chakraa@ccf.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228208664%22">The EMBO journal</searchLink> [EMBO J] 2026 Jun; Vol. 45 (11), pp. 3763-3787. <i>Date of Electronic Publication: </i>2026 Apr 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8208664 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1460-2075 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202614189%22">02614189 </searchLink><i>NLM ISO Abbreviation: </i>EMBO J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42020573 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s44318-026-00776-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3763 Titles: – TitleFull: Structure-guided optimization of SLC1A1/EAAT3-selective inhibitors targeting renal cancer metabolism. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Koochaki P – PersonEntity: Name: NameFull: Qiu B – PersonEntity: Name: NameFull: Coker JA – PersonEntity: Name: NameFull: Earsley A – PersonEntity: Name: NameFull: Wang NS – PersonEntity: Name: NameFull: Romigh T – PersonEntity: Name: NameFull: Goins CM – PersonEntity: Name: NameFull: Salem C – PersonEntity: Name: NameFull: Mi D – PersonEntity: Name: NameFull: Days E – PersonEntity: Name: NameFull: Bauer JA – PersonEntity: Name: NameFull: Stauffer SR – PersonEntity: Name: NameFull: Boudker O – PersonEntity: Name: NameFull: Chakraborty AA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1460-2075 Numbering: – Type: volume Value: 45 – Type: issue Value: 11 Titles: – TitleFull: The EMBO journal Type: main |
| ResultId | 1 |